Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon

Malaria Journal

Volumn 15, Issue 1, 2016, Pages

  Peixoto, Henry M ^a,b,c   Brito, Marcelo A M ^d,e   Romero, Gustavo A S ^a,c   Monteiro, Wuelton M ^d,e   De Lacerda, Marcus V G ^d,f   De Oliveira, Maria R F ^a,c  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b University Hospital of Brasilia   (Brazil)

^c National Institute for Science and Technology for Health Technology Assessment   (Brazil)

^d Tropical Medicine Foundation Dr Heitor Vieira Dourado   (Brazil)

^e UNIVERSIDADE DO ESTADO DO AMAZONAS   (Brazil)

^f INSTITUTO LEÔNIDAS E MARIA DEANE   (Brazil)

Author keywords

Cost effectiveness analysis; Economic analysis; Glucose 6 phosphate dehydrogenase deficiency; Haemolysis; Malaria; Plasmodium vivax; Primaquine

Indexed keywords

ARTICLE; BLOOD SAMPLING; BRAZILIAN; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC EQUIPMENT; DISEASE ASSOCIATION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MALE; PLASMODIUM VIVAX MALARIA; RAPID TEST; BRAZIL; COST BENEFIT ANALYSIS; DIAGNOSTIC TEST; ECONOMICS; ENZYMOLOGY; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; MALARIA, VIVAX;

BRAZIL; COST-BENEFIT ANALYSIS; DIAGNOSTIC TESTS, ROUTINE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; MALARIA, VIVAX;

EID: 84957812554     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-016-1140-x     Document Type: Article

References (50)

1. Monteiro WM, Franca GP, Melo GC, Queiroz ALM, Brito M, Peixoto HM, et al. Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes. Malar J. 2014;13:70.
2. Lacerda MVG, Fragoso SCP, Alecrim MGC, Alexandre MAA, Magalhães BML, Siqueira AM, et al. Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis. 2012;55:e67-74.
3. Ministério da Saúde: Guia prático de tratamento da malária no Brasil. Brasília; 2010.
4. Ministério da Saúde: Sistema de informação de Vigilância Epidemiológica da Malária (SIVEP-Malária) http://portalweb04.saude.gov.br/sivep-malaria/default.asp.
5. Ministério da Saúde: Sistema de Informação de Agravos de Notificação (SINAN) http://dtr2004.saude.gov.br/sinanweb/tabnet/dh?sinannet/malaria/bases/malabrnet.def.
6. Peixoto HM, Brito MA, Romero GA, Monteiro WM, Lacerda MV, Oliveira MRF. G6PD deficiency in male individuals infected by Plasmodium vivax malaria in the Brazilian Amazon: a cost study. Malar J. 2015;14:126.
7. Santana MS, Monteiro WM, Siqueira AM, Costa MF, Sampaio V, Lacerda MV, et al. Glucose-6-phosphate dehydrogenase deficient variants are associated with reduced susceptibility to malaria in the Brazilian Amazon. Trans R Soc Trop Med Hyg. 2013;107:301-6.
8. Kahn M, Larue N, Bansil P, Kalnoky M, McGray S, Domingo GJ. Cryopreservation of glucose-6-phosphate dehydrogenase activity inside red blood cells: developing a specimen repository in support of development and evaluation of glucose-6-phosphate dehydrogenase deficiency tests. Malar J. 2013;12:286.
9. Gething PW, Elyazar IRF, Moyes CL, Smith DL, Battle KE, Guerra CA, et al. A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis. 2012;6:e1814.
10. The malERA Consultative Group on Drugs. A research agenda for malaria eradication: drugs. PLoS Med. 2011;8:e1000402.
11. Monteiro WM, Val FF, Siqueira AM, Franca GP, Sampaio VS, Melo GC, et al. G6PD deficiency in Latin America: systematic review on prevalence and variants. Mem Inst Oswaldo Cruz. 2014;109:553-68.
12. Kim S, Nguon C, Guillard B, Duong S, Chy S, Sum S, et al. Performance of the carestart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS One. 2011;6:e28357.
13. Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, Carter N, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J. 2013;12:391.
14. Von Seidlein L, Auburn S, Espino F, Shanks D, Cheng Q, McCarthy J, et al. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malar J. 2013;12:112.
15. Tinley KE, Loughlin AM, Jepson A, Barnett ED. Evaluation of a rapid qualitative enzyme chromatographic test for glucose-6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg. 2010;82:210-4.
16. Osorio L, Carter N, Arthur P, Bancone G, Gopalan S, Gupta SK, et al. Performance of BinaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects. Am J Trop Med Hyg. 2015;92:22-7.
17. Eziefula AC, Gosling R, Hwang J, Hsiang MS, Bousema T, von Seidlein L, et al. Rationale for short course primaquine in Africa to interrupt malaria transmission. Malar J. 2012;11:360.
18. Roca-Feltrer A, Khim N, Kim S, Chy S, Canier L, Kerleguer A, et al. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia. PLoS One. 2014;9:e116143.
19. Recht J, Ashley E, White N. Safety of 8-aminoquinoline antimalarial medicines. Geneva: World Health Organization; 2014. http://www.who.int/malaria/publications/atoz/9789241506977/en/.
20. Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, et al. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. Lancet. 2014;383:1049-58.
21. Superintendência do Desenvolvimento da Amazônia: Amazônia Legal http://www.sudam.gov.br/amazonia-legal/demografia/50-amazonialegal.
22. Banco Central do Brasil: Taxas de Câmbio http://www4.bcb.gov.br/pec/taxas/port/ptaxnpesq.asp?id=txcotacao.
23. Ministério do Planejamento Orçamento e Gestão: Sistema Nacional de Índices de Preços ao Consumidor http://www.ibge.gov.br/home/estatistica/indicadores/precos/inpc-ipca/defaultseriesHist.shtm.
24. WHO. From malaria control to malaria elimination: a manual for elimination scenario planning. Geneva: World Health Organization; 2014.
25. Tatem AJ, Smith DL, Gething PW, Kabaria CW, Snow RW, Hay SI. Ranking of elimination feasibility between malaria-endemic countries. Lancet. 2010;376:1579-91.
26. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64-74.
27. Adu-Gyasi D, Asante KP, Newton S, Dosoo D, Amoako S, Adjei G, et al. Evaluation of the diagnostic accuracy of CareStart G6PD deficiency rapid diagnostic test (RDT) in a malaria endemic area in Ghana, Africa. PLoS One. 2015;10:e0125796.
28. Moorthy VS, Hutubessy R, Newman RD, Hombach J. Decision-making on malaria vaccine introduction: the role of cost-effectiveness analyses. Bull World Health Organ. 2012;90:864-6.
29. Seo MK, Baker P, Ngo KN-L. Cost-effectiveness analysis of vaccinating children in Malawi with RTS, S vaccines in comparison with long-lasting insecticide-treated nets. Malar J. 2014;13:66.
30. Tediosi F, Maire N, Penny M, Studer A, Smith TA. Simulation of the cost-effectiveness of malaria vaccines. Malar J. 2009;8:127.
31. Hanson K, Kikumbih N, Armstrong Schellenberg J, Mponda H, Nathan R, Lake S, et al. Cost-effectiveness of social marketing of insecticide-treated nets for malaria control in the United Republic of Tanzania. Bull World Health Organ. 2003;81:269-76.
32. Paintain SL, Awini E, Addei S, Kukula V, Nikoi C, Sarpong D, et al. Evaluation of a universal long-lasting insecticidal net (LLIN) distribution campaign in Ghana: cost effectiveness of distribution and hang-up activities. Malar J. 2014;13:71.
33. Crowell V, Briët OJ, Hardy D, Chitnis N, Maire N, Di Pasguale A, et al. Modeling the cost-effectiveness of mass screening and treatment for reducing Plasmodium falciparum malaria burden. Malar J. 2012;11:19.
34. Oliveira MRF, Giozza SP, Peixoto HM, Romero GAS. Cost-effectiveness of diagnostic for malaria in extra-Amazon Region. Brazil Malar J. 2012;11:390.
35. ® rapid diagnostic test for malaria in remote areas of the Amazon Region. Brazil Malar J. 2010;9:277.
36. Lubell Y, Riewpaiboon A, Dondorp AM, von Seidlein L, Mokuolu OA, Nansumba M, et al. Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa. Bull World Health Organ. 2011;89:504-12.
37. Kyaw S, Drake T, Ruangveerayuth R, Chierakul W, White NJ, Newton PN, et al. Cost of treating inpatient falciparum malaria on the Thai-Myanmar border. Malar J. 2014;13:416.
38. Massad E, Behrens BC, Coutinho FAB, Behrens RH. Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries. Malar J. 2011;10:130.
39. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD). Banco de dados - deficiência da glicose-6-fosfato-desidrogenase (2009-2011). Manaus: FMT-HVD; 2011.
40. Macauley C. Aggressive active case detection: a malaria control strategy based on the Brazilian model. Soc Sci Med. 2005;60:563-73.
41. Oliveira MRF. Cost-effectiveness analysis of rapid test for the diagnosis of new malaria cases in twelve endemic municipalities of the State of Pará. PhD thesis. Universidade de São Paulo, Faculdade de Saúde Pública; 2009.
42. Secretaria de Estado da Saúde do Amazonas (SES/AM). Tabela de vencimentos e gratificação de saúde. Manaus: SES/AM; 2013.
43. Secretaria de Vigilância em Saúde do Ministério da Saúde. Relação de compras de medicamentos para malária. Brasília, 2013.
44. Bosman A, Cunningham J. Proposal for an Evidence Review Group (ERG) on G6PD testing to support increased access to primaquine for radical cure of Plasmodium vivax and for malaria chemoprophylaxis. Geneva: World Health Organization; 2013.
45. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD): Relação de compras de insumos laboratoriais. Manaus; 2013.
46. Ministério da Saúde: Banco de Preços em Saúde http://aplicacao.saude.gov.br/bps/login.jsf.
47. São Paulo
48. Ministério da Saúde: Sistema de Gerenciamento da Tabela de Procedimentos, Medicamentos e OPM do SUS http://sigtap.datasus.gov.br/tabela-unificada/app/sec/inicio.jsp.
49. Ministério da Saúde: Sistema de Informação Hospitalar Descentralizados do SUS http://www2.datasus.gov.br/SIHD/.
50. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD): Custos com a nutrição hospitalar. Manaus: FMT-HVD; 2013.